Skip to main content

We are a coalition of doctors, researchers, patients, and entrepreneurs pioneering a new approach to curing diseases through innovative outcome-based financing. We collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.

Our Target is Chronic Pancreatitis

The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments within 10 years. Mission: Cure is working to make that happen. Consulting with pancreatic experts from the nation’s top research and healthcare institutions, we developed a 10-year plan and are working to implement it.

OUR APPROACH

Financing Based On Patient Outcomes

a male scientist holds a pipette and puts liquid into small containers surroudned by beakers in a lab

Promising And Cost-Effective Methods To Cure Diseases

five business people sit around a laptop engaged in conversation

Active Collaboration Among Stakeholders

two people point and review a paper with bar and pie graphs

Partnerships With Impact Investors

The time is right to create a new model for curing disease.  Exciting developments in genetics and data are making precision medicine a reality. Healthcare payers are moving toward value-based funding, especially for chronic diseases.  And a new generation of impact investors—seeking to generate social and not just financial returns—have made curing disease a priority.

DONATE

We cannot do this without your support.

Donate

News from Mission: Cure

November 2, 2022 in News

Now Hiring a Nonprofit Program Associate!

Your career at Mission:Cure can help improve the lives of people who are suffering and change the way diseases are cured   Are you ready to apply your talents to help an innovative nonprofit that is changing the model for curing disease while improving the lives of people who are suffering? Mission:Cure is a growing nonprofit organization that has made…
Read More
August 11, 2022 in Blog, Mission: Cure Updates, News

Getting Ready to Test New Pancreatitis Treatments: News from PancreasFest

When will we have new treatments for pancreatitis? In July, Mission: Cure met with researchers and doctors to discuss this important question. Mission: Cure CEO Megan Golden, VP for Translational Research Lola Rahib, and the summer interns attended PancreasFest 2022 at the University of Pittsburgh. PancreasFest is an annual conference that brings together researchers who treat pancreatic diseases. These experts…
Read More

Mission: Cure – Twitter